TY - JOUR
T1 - Optimal stapler cartridge selection according to the thickness of the pancreas in distal pancreatectomy
AU - Kim, Hongbeom
AU - Jang, Jin Young
AU - Son, Donghee
AU - Lee, Seungyeoun
AU - Han, Youngmin
AU - Shin, Yong Chan
AU - Kim, Jae Ri
AU - Kwon, Wooil
AU - Kim, Sun Whe
N1 - Publisher Copyright:
Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All.
PY - 2016
Y1 - 2016
N2 - Stapling is a popular method for stump closure in distal pancreatectomy (DP). However, research on which cartridges are suitable for different pancreatic thickness is lacking. To identify the optimal stapler cartridge choice in DP according to pancreatic thickness. From November 2011 to April 2015, data were prospectively collected from 217 consecutive patients who underwent DP with 3-layer endoscopic staple closure in Seoul National University Hospital, Korea. Postoperative pancreatic fistula (POPF) was graded according to International Study Group on Pancreatic Fistula definitions. Staplers were grouped based on closed length (CL) (Group I: CL 1.5mm, II: 1.5 mm < CL < 2mm, III: CL ? 2mm). Compression ratio (CR) was defined as pancreas thickness/CL. Distribution of pancreatic thickness was used to find the cut-off point of thickness which predicts POPF according to stapler groups. POPF developed in 130 (59.9%) patients (Grade A; n=86 [66.1%], B; n=44 [33.8%]). The numbers in each stapler group were 46, 101, and 70, respectively. Mean thickness was higher in POPF cases (15.2mm vs 13.5mm, P=0.002). High body mass index (P= 0.003), thick pancreas (P=0.011), and high CR (P=0.024) were independent risk factors for POPF in multivariate analysis. Pancreatic thickness was grouped into <12mm, 12 to 17mm, and >17mm. With pancreatic thickness <12mm, the POPF rate was lowest with Group II (I: 50%, II: 27.6%, III: 69.2%, P=0.035). The optimal stapler cartridges with pancreatic thickness <12mmwere those in Group II (Gold, CL: 1.8mm). There was no suitable cartridge for thicker pancreases. Further studies are necessary to reduce POPF in thick pancreases.
AB - Stapling is a popular method for stump closure in distal pancreatectomy (DP). However, research on which cartridges are suitable for different pancreatic thickness is lacking. To identify the optimal stapler cartridge choice in DP according to pancreatic thickness. From November 2011 to April 2015, data were prospectively collected from 217 consecutive patients who underwent DP with 3-layer endoscopic staple closure in Seoul National University Hospital, Korea. Postoperative pancreatic fistula (POPF) was graded according to International Study Group on Pancreatic Fistula definitions. Staplers were grouped based on closed length (CL) (Group I: CL 1.5mm, II: 1.5 mm < CL < 2mm, III: CL ? 2mm). Compression ratio (CR) was defined as pancreas thickness/CL. Distribution of pancreatic thickness was used to find the cut-off point of thickness which predicts POPF according to stapler groups. POPF developed in 130 (59.9%) patients (Grade A; n=86 [66.1%], B; n=44 [33.8%]). The numbers in each stapler group were 46, 101, and 70, respectively. Mean thickness was higher in POPF cases (15.2mm vs 13.5mm, P=0.002). High body mass index (P= 0.003), thick pancreas (P=0.011), and high CR (P=0.024) were independent risk factors for POPF in multivariate analysis. Pancreatic thickness was grouped into <12mm, 12 to 17mm, and >17mm. With pancreatic thickness <12mm, the POPF rate was lowest with Group II (I: 50%, II: 27.6%, III: 69.2%, P=0.035). The optimal stapler cartridges with pancreatic thickness <12mmwere those in Group II (Gold, CL: 1.8mm). There was no suitable cartridge for thicker pancreases. Further studies are necessary to reduce POPF in thick pancreases.
KW - Compression
KW - Distal pancreatectomy
KW - Fistula
KW - Pancreas
KW - Risk factor
KW - Surgical stapler
KW - Thickness
UR - https://www.scopus.com/pages/publications/84987753790
U2 - 10.1097/MD.0000000000004441
DO - 10.1097/MD.0000000000004441
M3 - Article
C2 - 27583852
AN - SCOPUS:84987753790
SN - 0025-7974
VL - 95
JO - Medicine (United States)
JF - Medicine (United States)
IS - 35
M1 - e4441
ER -